TY - CHAP
T1 - Photobiomodulation Therapy for Other Brain-Related Disorders
AU - Salehpour, Farzad
AU - Sadigh-Eteghad, Saeed
AU - Mahmoudi, Javad
AU - Kamari, Farzin
AU - Cassano, Paolo
AU - Hamblin, Michael Richard
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive license to Springer Nature Switzerland AG.
PY - 2023
Y1 - 2023
N2 - This chapter investigates the potential of photobiomodulation (PBM) therapy for various other brain-related disorders, providing an overview of each condition and examining the therapeutic approach in both animal studies and human clinical trials. Section 14.1 focuses on disorders of consciousness and vegetative state, introducing the topic (14.1.1) and exploring PBM therapy for these disorders in human studies (14.1.2), emphasizing its potential to improve neurological function and enhance the recovery process. Section 14.2 covers multiple sclerosis, discussing the problem of multiple sclerosis (14.2.1), PBM therapy for multiple sclerosis in animal studies (14.2.2), and its application in human clinical trials (14.2.3). The chapter highlights the potential benefits of PBM therapy for managing symptoms and improving the quality of life for individuals affected by this complex neurological condition. Section 14.3 addresses drug addiction, discussing the application of PBM therapy for drug addiction in animal studies (14.3.1). The section presents promising findings and areas for future research to better understand the potential therapeutic effects of PBM in the context of addiction. Section 14.4 focuses on epilepsy, examining the use of PBM therapy for epilepsy in animal studies (14.4.1). This section highlights the potential for PBM therapy to reduce seizure frequency and severity, while emphasizing the need for further investigation to optimize treatment parameters and validate its efficacy in human subjects.
AB - This chapter investigates the potential of photobiomodulation (PBM) therapy for various other brain-related disorders, providing an overview of each condition and examining the therapeutic approach in both animal studies and human clinical trials. Section 14.1 focuses on disorders of consciousness and vegetative state, introducing the topic (14.1.1) and exploring PBM therapy for these disorders in human studies (14.1.2), emphasizing its potential to improve neurological function and enhance the recovery process. Section 14.2 covers multiple sclerosis, discussing the problem of multiple sclerosis (14.2.1), PBM therapy for multiple sclerosis in animal studies (14.2.2), and its application in human clinical trials (14.2.3). The chapter highlights the potential benefits of PBM therapy for managing symptoms and improving the quality of life for individuals affected by this complex neurological condition. Section 14.3 addresses drug addiction, discussing the application of PBM therapy for drug addiction in animal studies (14.3.1). The section presents promising findings and areas for future research to better understand the potential therapeutic effects of PBM in the context of addiction. Section 14.4 focuses on epilepsy, examining the use of PBM therapy for epilepsy in animal studies (14.4.1). This section highlights the potential for PBM therapy to reduce seizure frequency and severity, while emphasizing the need for further investigation to optimize treatment parameters and validate its efficacy in human subjects.
UR - http://www.scopus.com/inward/record.url?scp=85169018438&partnerID=8YFLogxK
U2 - 10.1007/978-3-031-36231-6_14
DO - 10.1007/978-3-031-36231-6_14
M3 - Chapter
AN - SCOPUS:85169018438
T3 - Synthesis Lectures on Biomedical Engineering
SP - 317
EP - 333
BT - Synthesis Lectures on Biomedical Engineering
PB - Springer Nature
ER -